Top list · Worldwide

Antibodies startups worldwide

68 antibodies startups worldwide have raised money in rounds we track. These are the 50 that have raised the most, $3.3B between them, with the United States the most common home.

$3.3Braised by these 50
68on our record in all
United Statesmost common home
NovImmuneraised the most
  1. 1NovImmuneNovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

    NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

    Founded 1998Plan-les-Ouates, Switzerland$352Mlast round Feb 2014
  2. 2AtrecaAtreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

    Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

    Founded 2010United States$313Mlast round Jul 2020
  3. 3AllakosAllakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

    Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

    Founded 2012Redwood City, United States$294Mlast round Sept 2022
  4. 4Alentis TherapeuticsAlentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland.

    Alentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland.

    Founded 2019Allschwil, Switzerland$194Mlast round Nov 2024
  5. 5VectorYVectorY Therapeutics is an Amsterdam-based biotechnology company founded in August 2020.

    VectorY Therapeutics is an Amsterdam-based biotechnology company founded in August 2020.

    Founded 2020Amsterdam, Netherlands$138Mlast round Nov 2023
  6. 6Innate PharmaInnate Pharma S.A.

    Innate Pharma S.A.

    Founded 1999Marseille, France$134Mlast round Jun 2014
  7. 7Diagonal TherapeuticsDiagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe genetic diseases.

    Diagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe genetic diseases.

    Founded 2022Watertown, United States$125Mlast round Jan 2026
  8. 8InvivydInvivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

    Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

    Founded 2020Waltham, United States$125Mlast round Nov 2025
  9. 9Merida BiosciencesMerida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for autoimmune and allergic diseases.

    Merida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for autoimmune and allergic diseases.

    Founded 2022Cambridge, United States$121Mlast round Apr 2025
  10. 10AgomAB TherapeuticsAgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

    AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

    Founded 2017Antwerpen, Belgium$112Mlast round Oct 2024
  11. 11Bambusa TherapeuticsBambusa Therapeutics is a biotechnology company based in Boston's Seaport, founded in May 2024.

    Bambusa Therapeutics is a biotechnology company based in Boston's Seaport, founded in May 2024.

    Founded 2024Boston, United States$90Mlast round Nov 2025
  12. 12PrecirixPrecirix is a clinical-stage biotechnology company based in Brussels, Belgium, founded in 2014.

    Precirix is a clinical-stage biotechnology company based in Brussels, Belgium, founded in 2014.

    Founded 2014Jette, Belgium$88Mlast round Mar 2022
  13. 13varnotechVarnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.

    Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.

    Founded 2019China$83Mlast round Mar 2024
  14. 14AdageneAdagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

    Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

    Founded 2011China$83Mlast round Jul 2025
  15. 15Ra PharmaceuticalsRa Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.

    Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.

    Founded 2008United States$77Mlast round Jul 2015
  16. 16LigoCyte PharmaceuticalsLigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications.

    LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications.

    Founded 1998United States$72Mlast round Jun 2012
  17. 17SciRhomSciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016.

    SciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016.

    Founded 2016Planegg, Germany$68Mlast round Jul 2024
  18. 18Rondo TherapeuticsRondo Therapeutics is a clinical-stage biopharmaceutical company based in Hayward, California, focused on developing next-generation T-cell engaging bispecific

    Rondo Therapeutics is a clinical-stage biopharmaceutical company based in Hayward, California, focused on developing next-generation T-cell engaging bispecific

    Founded 2021Hayward, United States$67Mlast round Mar 2022
  19. 19VelaVigoVelaVigo is a biotech company that specializes in the discovery and development of multi-specific antibodies and antibody-drug conjugates (ADCs).

    VelaVigo is a biotech company that specializes in the discovery and development of multi-specific antibodies and antibody-drug conjugates (ADCs).

    Founded 2021Shanghai, China$60Mlast round Jul 2025
  20. 20Rinat NeuroscienceA leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat.

    A leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat.

    Founded 2000United States$58Mlast round Aug 2003
  21. 21Third Arc BioThird Arc Bio is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, founded in 2022.

    Third Arc Bio is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, founded in 2022.

    Founded -Philadelphia, United States$52Mlast round Feb 2026
  22. 22Metaphore BiotechnologiesMetaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.

    Metaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.

    Founded 2021Cambridge, United States$50Mlast round Apr 2026
  23. 23Cytovance BiologicsCytovance Biologics produces therapeutic proteins and antibodies from mammalian cell cultures and microbial fermentations.

    Cytovance Biologics produces therapeutic proteins and antibodies from mammalian cell cultures and microbial fermentations.

    Founded 2005Oklahoma City, United States$43Mlast round Oct 2014
  24. 24ImaginAbImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

    ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

    Founded 2007Inglewood, United States$42Mlast round Oct 2017
  25. 25AdimabAdimab is a leader in the discovery and engineering of fully human monoclonal and multispecific antibodies.

    Adimab is a leader in the discovery and engineering of fully human monoclonal and multispecific antibodies.

    Founded 2007Lebanon, United States$40Mlast round Apr 2012
  26. 26XencorProteins by Design Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer.

    Proteins by Design Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer.

    Founded 1997Pasadena, United States$36Mlast round Jul 2013
  27. 27ExcelimmuneExcelimmune is a biopharmaceutical company developing fully human recombinant polyclonal antibodies for therapeutics.

    Excelimmune is a biopharmaceutical company developing fully human recombinant polyclonal antibodies for therapeutics.

    Founded 2006Lexington, United States$34Mlast round Jan 2012
  28. 28Sorriso PharmaceuticalsSorriso Pharmaceuticals is a private biopharmaceutical company founded in 2020, based in Sandy, Utah.

    Sorriso Pharmaceuticals is a private biopharmaceutical company founded in 2020, based in Sandy, Utah.

    Founded 2020San Diego, United States$31Mlast round Dec 2021
  29. 29KanovaKanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases.

    Kanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases.

    Founded 2015China$30Mlast round Jul 2023
  30. 30SparX GroupSparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.

    SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.

    Founded 2021Grand Cayman, Cayman Islands$30Mlast round Dec 2021
  31. 31GaluxGalux is a biotechnology company based in Seoul, South Korea, founded in 2020.

    Galux is a biotechnology company based in Seoul, South Korea, founded in 2020.

    Founded 2020South Korea$29Mlast round Feb 2026
  32. 32April BioApril Bio is a drug development company that develops antibodies and long-acting biologics.

    April Bio is a drug development company that develops antibodies and long-acting biologics.

    Founded 2013Chuncheon$22Mlast round Aug 2021
  33. 33Protillion BiosciencesProtillion Biosciences is a biotechnology company based in Carlsbad, California, focused on discovering and optimizing therapeutic antibodies and protein-based drugs.

    Protillion Biosciences is a biotechnology company based in Carlsbad, California, focused on discovering and optimizing therapeutic antibodies and protein-based drugs.

    Founded 2019Carlsbad, United States$18Mlast round Dec 2022
  34. 34Capella BioScienceCapella Bioscience engages in the discovery and development of monoclonal antibodies.

    Capella Bioscience engages in the discovery and development of monoclonal antibodies.

    Founded 2014United Kingdom$16Mlast round Mar 2016
  35. 35CEVEC PharmaceuticalsCEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.

    CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.

    Founded 2003Germany$14Mlast round Jul 2011
  36. 36AntiverseAntiverse is a techbio company based in Cardiff, UK, with an office in Boston, MA.

    Antiverse is a techbio company based in Cardiff, UK, with an office in Boston, MA.

    Founded 2017Rhoose, United Kingdom$14Mlast round Jun 2026
  37. 37Zumutor BiologicsZumutor Biologics is a clinical-stage immuno-oncology company founded in 2013, focused on developing first-in-class monoclonal antibodies that target Natural Ki

    Zumutor Biologics is a clinical-stage immuno-oncology company founded in 2013, focused on developing first-in-class monoclonal antibodies that target Natural Ki

    Founded 2015Cambridge, United States$14Mlast round Jun 2026
  38. 38AnimabAnimab is a Belgian biotechnology company founded in 2020, focused on developing orally administered monoclonal antibodies to protect livestock from gastrointes

    Animab is a Belgian biotechnology company founded in 2020, focused on developing orally administered monoclonal antibodies to protect livestock from gastrointes

    Founded 2020Ghent, Belgium$12Mlast round Jul 2025
  39. 39Kenta BiotechKenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections.

    Kenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections.

    Founded 2006Switzerland$10Mlast round Mar 2009
  40. 40Aptitude Medical SystemsAptitude Medical Systems focuses on the potential of aptamers to solve the fundamental problems of antibodies.

    Aptitude Medical Systems focuses on the potential of aptamers to solve the fundamental problems of antibodies.

    Founded 2011Minneapolis, United States$10Mlast round Jul 2025
  41. 41DJS AntibodiesDJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.

    DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.

    Founded 2014Headington$8.0Mlast round Dec 2020
  42. 42Genesis BiopharmaGenesis Biopharma – your top source for biotech and pharma needs.

    Genesis Biopharma – your top source for biotech and pharma needs.

    Founded 2023United States$7.7Mlast round Jun 2013
  43. 43Affomix CorporationAffomix develops technology for the automated, high-throughput selection of human monoclonal antibodies.

    Affomix develops technology for the automated, high-throughput selection of human monoclonal antibodies.

    Founded 2006United States$7.0Mlast round Feb 2008
  44. 44Cantai TherapeuticsCantai Therapeutics is a biotechnology company dedicated to developing bispecific antibodies aimed at treating autoimmune and inflammatory diseases.

    Cantai Therapeutics is a biotechnology company dedicated to developing bispecific antibodies aimed at treating autoimmune and inflammatory diseases.

    Founded 2023Philadelphia, United States$6.5Mlast round Jan 2026
  45. 45BioGenes TechnologiesBiogenes Technologies is a Malaysian biotechnology startup founded in 2015, focused on molecular diagnostics and genomics.

    Biogenes Technologies is a Malaysian biotechnology startup founded in 2015, focused on molecular diagnostics and genomics.

    Founded 2015Kuala Lumpur, Malaysia$5.7Mlast round Jan 2023
  46. 46DotBioDotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.

    DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.

    Founded 2017Singapore, Singapore$5.6Mlast round Aug 2023
  47. 47GamaMabs PharmaGamaMabs Pharma is a French biotechnology company specializing in immuno-oncology and the development of therapeutic monoclonal antibodies for cancer treatment,

    GamaMabs Pharma is a French biotechnology company specializing in immuno-oncology and the development of therapeutic monoclonal antibodies for cancer treatment,

    Founded 2013Toulouse, France$4.0Mlast round Sept 2013
  48. 48Orega BiotechOREGA Biotech is a French biotechnology company founded in 2010, specializing in the discovery and development of first-in-class monoclonal antibodies for cance

    OREGA Biotech is a French biotechnology company founded in 2010, specializing in the discovery and development of first-in-class monoclonal antibodies for cance

    Founded 2010Ecully, France$3.7Mlast round Sept 2010
  49. 49PanosomePanosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.

    Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.

    Founded -Heidelberg, Germany$3.4Mlast round Jun 2024
  50. 50Harbour AntibodiesHarbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.

    Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.

    Founded 2006Newton, United States$3.2Mlast round Jul 2013
Total fundinghow the list is ranked
15 November 2026updated nightly
Rounds we tracksource: Millionrounds

Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.

Who backed them?

Open any company for its rounds and investors, or search the investors who back antibodies startups worldwide in the app, with filters, lists and exports.

Find their investorsAll top lists

More lists worldwide

See all
GVVRPHealth startups worldwide12,811 companies · $81BOAXAI startups worldwide10,238 companies · $830BGVVRPBiotech startups worldwide7,127 companies · $70BDBFTBig data startups worldwide3,812 companies · $220BAFRSFintech startups worldwide3,200 companies · $94BOABAI startups that raised in 20262,922 companies · $540B in 2026FTCEPEnergy providers startups worldwide2,808 companies · $152BAPOMarketing tech startups worldwide2,728 companies · $28B